Skip to main content
logo
Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
8.79
-0.30 (-3.30%)
At close: May 15, 2026, 4:00 PM EDT
8.65
-0.14 (-1.59%)
After-hours: May 15, 2026, 7:57 PM EDT

Vir Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1,4828411,0051,3563,3725,492
Market Cap Growth
76.60%-16.34%-25.86%-59.79%-38.59%60.94%
Enterprise Value
1,102463.07190.07-54.841,0944,917
Last Close Price
8.796.037.3410.0625.3141.87
PE Ratio
--1.91-1.92-2.196.6110.57
Forward PE
-----18.86
PS Ratio
22.6312.2713.5515.732.095.01
PB Ratio
1.740.430.530.851.623.84
P/TBV Ratio
0.580.430.520.851.643.90
P/FCF Ratio
--2.12-2.22-1.692.11-79.12
P/OCF Ratio
--2.15-2.25-1.742.03-115.40
EV/Sales Ratio
16.826.752.56-0.640.684.49
EV/EBITDA Ratio
--0.99-0.330.081.3011.53
EV/EBIT Ratio
--0.97-0.320.081.3111.69
EV/FCF Ratio
--1.17-0.420.070.69-70.85
Debt / Equity Ratio
0.040.050.050.070.060.09
Debt / EBITDA Ratio
-0.19-0.19-0.16-0.170.150.31
Debt / FCF Ratio
-0.19-0.22-0.20-0.140.08-1.92
Net Debt / Equity Ratio
-0.18-0.19-0.43-0.89-1.10-0.40
Net Debt / EBITDA Ratio
0.850.811.422.12-2.71-1.35
Net Debt / FCF Ratio
0.870.951.801.76-1.438.28
Asset Turnover
0.060.060.040.040.680.76
Quick Ratio
6.485.037.578.684.704.34
Current Ratio
7.115.548.719.054.934.58
Return on Equity (ROE)
-21.60%-22.62%-29.82%-33.54%29.39%49.20%
Return on Assets (ROA)
-46.59%-39.94%-35.32%-28.39%23.96%28.16%
Return on Invested Capital (ROIC)
-102.85%-115.16%-173.35%-702.98%125.54%73.35%
Return on Capital Employed (ROCE)
-50.70%-43.79%-38.85%-33.92%42.68%34.59%
Earnings Yield
-29.86%-52.40%-52.18%-45.63%15.13%9.46%
FCF Yield
-30.33%-47.16%-45.13%-59.03%47.31%-1.26%
Buyback Yield / Dilution
-3.07%-1.67%-1.58%0.50%-1.03%-11.98%
Total Shareholder Return
-3.07%-1.67%-1.58%0.50%-1.03%-11.98%
Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q